BreezeBio is a biotechnology company developing precision genetic medicines enabled by targeted, non-viral delivery across biologically relevant tissues. Using our proprietary NanoGalaxy® platform, we engineer nanoparticles designed to deliver genetic payloads, including mRNA, to specific cell types. Our platform has demonstrated delivery to immune cells as well as select tissues in the heart, lung, and central nervous system. We are advancing an internal therapeutic pipeline focused on autoimmune diseases and oncology. Our lead program, BRZ-101, is designed to restore immune tolerance in type 1 diabetes and is advancing into IND-enabling studies. BreezeBio is headquartered in the South San Francisco area.
| Website | http://www.breezebio.com |
| Employees | 64 (39 on RocketReach) |
| Address | 3000 Marina Blvd 350, Brisbane, California 94005, US |
| Industry | Biotechnology Research |
Looking for a particular GenEdit employee's phone or email?
Kunwoo Lee is the Chief Executive Officer and Co-founder of GenEdit.
39 people are employed at GenEdit.
GenEdit is based in Brisbane, California.